Press Releases

Date	Title	Company
03-May-2022	Industry Leader, Tyler Painter, Joins Wisk as Chief Financial Officer	Wisk Aero
03-May-2022	Elligo Launches European Operations to Enable Research Through Healthcare	Elligo
03-May-2022	The AscellaHealth Family of Companies Expands Executive Team Leadership for Ongoing Support of Strategic Business Initiatives and Accelerated Growth	AscellaHealth
03-May-2022	Matica Bio Opens New Cell and Gene Therapy GMP Facility in Texas	Matica Bio
03-May-2022	Tierra Biosciences Appoints Michael Nemzek as Chief Executive Officer	Tierra Biosciences
03-May-2022	X-Therma Receives FDA Breakthrough Device Designation for XT-ViVo® Preservation Solution and TimeSeal® Organ Transport Device	Businesswire
03-May-2022	AbCellera and Empirico Expand Strategic Multi-Target Antibody Discovery Collaboration	Businesswire
03-May-2022	Cyteir Therapeutics Names Krisztina Nemenyi as Senior Vice President of Regulatory Affairs and Quality	Businesswire
03-May-2022	Xilis Participates in €325MM Oncode-PACT Consortium to Accelerate the Development of Cancer Drugs	Businesswire
03-May-2022	AmerisourceBergen & Biopharmaceutical Companies Discuss Strategies to Advance Pharmaceutical Innovation and Access at ThinkLive Commercialization Conference	Businesswire
03-May-2022	Global Lecithin & Phospholipids Markets Report 2022-2027: Growing Demand for Natural Food Additives and Increasing Consumer Awareness About Clean-Label Products Propelling the Market - ResearchAndMarkets.com	Businesswire
03-May-2022	Affini-T Therapeutics’ KRAS TCR T Cell Therapy Program to be Presented at the Annual Meeting of the American Society of Gene and Cell Therapy	Businesswire
03-May-2022	Stratpharma AG Appoints Michael Flowers President, North America Commercial Operations	Businesswire
03-May-2022	Robotics & AI Industry Leader Fady Saad and Automation & Sensor Industry Executive Mark Martin Launch First-of-its-Kind $50 Million Fund For Early-Stage Robotics, Automation, and AI Companies	Businesswire
03-May-2022	Worldwide Clinical Trials Names Rosemarie Corrigan Executive Vice President, Global Quality	Businesswire
03-May-2022	Sesen Bio Provides Strategic Update	Businesswire
03-May-2022	Tenaya Therapeutics to Present Preclinical Data on Gene Therapy Programs and Platform Capabilities at the American Society of Gene and Cell Therapy 25th Annual Meeting	Businesswire
03-May-2022	Seismic Therapeutic Appoints Maude Tessier, PhD, as Chief Business Officer	Businesswire
03-May-2022	Revolutionizing Quat Pesticide Determination and Quantitation Workflows to Protect Food Supply	Businesswire
03-May-2022	U.S. FDA Accepts Supplemental New Drug Application (sNDA) and Grants Priority Review for NUBEQA® (darolutamide) in Combination with Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)	Businesswire